跳至主要内容
临床试验/NCT02726971
NCT02726971已完成1 期

A Prospective, Randomized, Controlled Trial Comparing 2 Different Doses of Estrogen Therapy After Hysteroscopic Adhesiolysis as an Adjuvant to Prevent Recurrence of Intrauterine Adhesions

Fu Xing Hospital, Capital Medical University1 个研究点 分布在 1 个国家目标入组 141 人开始时间: 2016年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
141
试验地点
1
主要终点
the AFS Score at Second-look Hysteroscopy

研究概览

简要总结

This single-center,prospective,randomized,controlled trial is conducted to evaluate the efficacy of different doses of estrogen artificial periodic therapy after hysteroscopic adhesiolysis in patients with moderate-severe adhesion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
25 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Moderate and severe IUA according to the AFS IU adhesion scoring system (AFS 1988 version) (19) showed in Table1 (AFS score≥5);
  • Scheduled for hysteroscopic adhesiolysis;
  • Agreed to have two follow-up hysteroscopy; and
  • Written, informed consent obtained.

排除标准

  • Received estrogen therapy within 3 months of enrollment;
  • Suffering from leiomyoma, polyps, cancer, or polycystic ovarian syndrome (PCOS);
  • History of genital tuberculosis; and
  • Contraindication for estrogen therapy.

研究组 & 干预措施

Low dose of oestrogen

Experimental

Patients in this group will build artificial cycle by Femoston.(oral one red tablet daily for 11 days and oral one yellow tablet in the next 10 days). This process will last for 3 months after the surgery.

P.S.1.A red tablet contains 2mg estradiol. 2.A yellow tablet contains 2mg estradiol and 10mg dydrogesterone.

干预措施: Femoston (Drug)

High dose of oestrogen

Active Comparator

Patients in this group will build artificial cycle by Femoston.(oral three red tablets daily for 11 days and oral two yellow tablets in the next 10 days). This process will last for 3 months after the surgery.

P.S.1.A red tablet contains 2mg estradiol. 2.A yellow tablet contains 2mg estradiol and 10mg dydrogesterone.

干预措施: Femoston (Drug)

结局指标

主要结局

the AFS Score at Second-look Hysteroscopy

时间窗: 1 months after the surgery

The AFS score is based on the American Fertility Society (AFS) Classification of Intra-uterine adhesions( 1988 version)The total range of AFS score is from 0 to 12, and the higher the score is, the worse the outcome is.

次要结局

  • the AFS Score at Third-look Hysteroscopy(2 months after surgery)
  • Participants With Improvement of Menstrual Pattern at Third-look Hysteroscopy(3 months after surgery)

研究者

发起方
Fu Xing Hospital, Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jun Guo

Chief Physician

Fu Xing Hospital, Capital Medical University

研究点 (1)

Loading locations...

相似试验

Comparison of Different Doses of Oestrogen Therapy... | 临床试验